Baton Rouge Mall shooting victims family is suing the malls owners, FDA says abortion pill study will finish in December, POTUS announced the U.S. wont attack Iran.

A court-ordered status update said the agency does not plan to implement any restrictions while its review of the pill ...

The Food and Drug Administration (FDA) has postponed until perhaps March 2027 the release of a safety study on the abortion ...

The Food and Drug Administration (FDA) won’t publish its safety review of the abortion drug mifepristone until March, it disclosed in a Wednesday court filing, adding that it won’t impose any new ...

The Food and Drug Administration says its ongoing safety review of the nation’s main abortion pill will continue into next ...

The ​Trump administration plans to complete a review of the abortion drug mifepristone by March 2027, according ‌to a court ...

The U.S. Food and Drug Administration said late Wednesday that it expects to complete its long-awaited safety review of abortion pills by mid-December and issue a report evaluating the results by ...

Three Republican-led U.S. states are testing a new legal argument as they seek to restrict the distribution of abortion pills ...

The FDA, in a Wednesday legal filing, said that its much-anticipated review of the abortion drug mifepristone won’t be ...

Anti-abortion groups plan to urge states to require ultrasounds, waiting periods and in-person visits for abortion pills as federal telehealth rules are reviewed.

The effort comes as federal officials continue reviewing regulations governing medication abortions. Current FDA guidelines allow abortion pills to be prescribed through telehealth without requiring ...